Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Ventuals shuts down OpenAI and Anthropic perpetual markets on Hyperliquid, joining another project.

Market News
15 Jun 2026
Coindesk
View Source
Neutral
pluang ai news

Ventuals, the team behind perpetual futures markets for OpenAI and Anthropic on the Hyperliquid exchange, is closing its markets and merging with another project within the Hyperliquid ecosystem. Trading in these markets has stopped and all positions were settled automatically. This marks a consolidation trend in the growing crypto derivatives space, where Hyperliquid leads with $234 billion in monthly volume. Ventuals had generated over $650 million in trading volume and attracted significant community support before shutting down. The closure highlights the rise of dominant players like TradeXYZ, which now controls nearly 97% of similar market volumes on Hyperliquid.

More News

Prediction market sees low chance of Starlink IPO before mid-2027 despite SpaceX's $1T revenue goal.

Prediction market sees low chance of Starlink IPO before mid-2027 despite SpaceX's $1T revenue goal.

Elon Musk's SpaceX recently went public, raising questions about a potential IPO for its Starlink subsidiary. Data from prediction market Kalshi shows only a 7-10% chance of a Starlink IPO announcement before mid-2027. Meanwhile, Musk predicts SpaceX...

Market News
Neutral
39 minutes ago
Goodfirms releases 2026 tech vendor rankings based on 1.2M+ verified reviews across six key categories.

Goodfirms releases 2026 tech vendor rankings based on 1.2M+ verified reviews across six key categories.

Goodfirms has published its 2026 rankings of top technology service providers across six categories: mobile app, software, web development, digital marketing, SEO, and AI development. These rankings are based on over 1.2 million verified client revie...

Others
Neutral
1 hour ago
Alvotech prices $152M share offering and private placement to fund biosimilar development

Alvotech prices $152M share offering and private placement to fund biosimilar development

Alvotech announced a $152 million public offering and concurrent private placement of ordinary shares priced at $3.75 each. The public offering includes 22.7 million shares, with an option for underwriters to buy an additional 3.4 million shares. The...

Company Fundamentals
Bullish
2 hours ago
Alvotech prices $152M share offering in US and Europe to fund biotech drug development.

Alvotech prices $152M share offering in US and Europe to fund biotech drug development.

Alvotech announced pricing and allocation of a $152 million public share offering in the US and a concurrent private placement in Europe at $3.75 per share. The company expects total proceeds up to $165 million if underwriters exercise their full opt...

Company Fundamentals
Bullish
2 hours ago
Oxford Industries faces fraud investigation after revenue guidance cut triggers share drop

Oxford Industries faces fraud investigation after revenue guidance cut triggers share drop

The Schall Law Firm has launched an investigation into Oxford Industries following the company's sharp revenue guidance cut on June 10, 2026, which caused a significant drop in its share price. The probe focuses on whether Oxford issued false or misl...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App